• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度北部口腔黏膜下纤维化的临床特征及各种治疗方式评估:我们的经验

Evaluation of Clinical Profile and Various Treatment Modalities in Oral Sub Mucous Fibrosis in North India: Our Experience.

作者信息

Verma Pankaj Kumar, Rana Amit Kumar, Tripathi Swati, Kumar Shivesh, Upadhyay Deepak

机构信息

Department of ENT, Integral Institute of Medical Sciences & Research, Lucknow, Uttar Pradesh India.

Department of Otolaryngology and Head Neck Surgery, Shri Ram Murti Smarak Institute of Medical Sciences, Bareilly, Uttar Pradesh India.

出版信息

Indian J Otolaryngol Head Neck Surg. 2022 Dec;74(Suppl 3):6313-6320. doi: 10.1007/s12070-021-03049-y. Epub 2022 Jan 8.

DOI:10.1007/s12070-021-03049-y
PMID:36742589
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9895579/
Abstract

Oral submucous fibrosis is a chronic disease affecting oral cavity and sometimes the pharynx. Etiology seems to be local irritants such as capsaicin, tobacco, areca nut and spicy foods. The main concern in this is the management of trismus and burning sensation of the oral mucosa. The aim of this study was to compare various medical treatment protocol of OSMF. 210 patients were divided randomly in 3 groups. In Group A, patients were given biweekly intralesional Hyaluronidase/Dexamethasone for 6 weeks. Group B patients were given tablet Pentoxifylline 400 mg TDS.Group C patients were given Eprisone hydrochloride. All three groups were given Lycopene 10,000 mcg for period of 6 weeks. All patients were given topical Triamcelone for local application. The examinations for mouth opening were repeated at weekly intervals for a period of 6 weeks.The most common complaint was burning sensation in 75.98% cases, difficulty in mouth opening in77.45% and difficulty in swallowing food in 61.76% cases. Group A showed improvement in 41.17% cases presenting with burning sensation followed by decreased mouth opening 39.70%. Group B showed improvement in 45.58% burning sensation, 17.64% with decreased mouth opening. Group C showed improvement in 48.52% patients having pain with spicy food, 32.35% with decreased mouth opening and 17.64% with difficulty in swallowing. We conclude that patients which received intralesional dexamethasone and hyaluronidase along with oral Lycopene showed better clinical and symptomatic improvement, and at present appears to be best non-surgical treatment.

摘要

口腔黏膜下纤维化是一种影响口腔,有时也会影响咽部的慢性疾病。病因似乎是辣椒素、烟草、槟榔和辛辣食物等局部刺激物。其中主要关注的是牙关紧闭和口腔黏膜烧灼感的处理。本研究的目的是比较口腔黏膜下纤维化的各种医学治疗方案。210名患者被随机分为3组。A组患者每两周接受一次病灶内注射透明质酸酶/地塞米松,共6周。B组患者服用己酮可可碱片,400毫克,每日三次。C组患者服用盐酸乙哌立松。所有三组患者均服用番茄红素10000微克,为期6周。所有患者均给予局部应用曲安奈德。在6周的时间里,每周重复进行一次张口检查。最常见的主诉是75.98%的病例有烧灼感,77.45%的病例张口困难,61.76%的病例吞咽食物困难。A组中,41.17%有烧灼感的病例症状改善,其次是张口受限改善39.70%。B组中,45.58%的烧灼感症状改善,17.64%的张口受限症状改善。C组中,48.52%吃辛辣食物疼痛的患者症状改善,32.35%的张口受限症状改善,17.64%的吞咽困难症状改善。我们得出结论,接受病灶内注射地塞米松和透明质酸酶以及口服番茄红素的患者在临床和症状方面改善更好,目前似乎是最佳的非手术治疗方法。

相似文献

1
Evaluation of Clinical Profile and Various Treatment Modalities in Oral Sub Mucous Fibrosis in North India: Our Experience.印度北部口腔黏膜下纤维化的临床特征及各种治疗方式评估:我们的经验
Indian J Otolaryngol Head Neck Surg. 2022 Dec;74(Suppl 3):6313-6320. doi: 10.1007/s12070-021-03049-y. Epub 2022 Jan 8.
2
Evaluation of Therapeutic Efficacy of Different Treatment Modalities in Oral Submucous Fibrosis: A Comparative Study.不同治疗方式对口腔黏膜下纤维化的治疗效果评估:一项对比研究。
J Contemp Dent Pract. 2019 Mar 1;20(3):390-394.
3
A comparative study to evaluate the efficacy of lycopene and curcumin in oral submucous fibrosis patients: A randomized clinical trial.一项评估番茄红素和姜黄素对口腔黏膜下纤维化患者疗效的比较研究:一项随机临床试验。
Indian J Dent Res. 2018 May-Jun;29(3):303-312. doi: 10.4103/ijdr.IJDR_551_16.
4
Comparative assessment of the efficacy of an intralesional injection of placentrex, hyaluronidase and dexamethasone in the management of oral submucous fibrosis: A randomized controlled trial.病灶内注射胎盘组织液、透明质酸酶和地塞米松治疗口腔黏膜下纤维化疗效的比较评估:一项随机对照试验。
Med Int (Lond). 2024 Feb 26;4(2):19. doi: 10.3892/mi.2024.143. eCollection 2024 Mar-Apr.
5
Comparison of Efficacy of Lycopene and Lycopene-Hyaluronidase Combination in the Treatment of Oral Submucous Fibrosis.番茄红素与番茄红素-透明质酸酶联合用药治疗口腔黏膜下纤维化的疗效比较
J Pharm Bioallied Sci. 2019 May;11(Suppl 2):S260-S264. doi: 10.4103/JPBS.JPBS_6_19.
6
Comparison of Intralesional Placentrex Versus Hyaluronidase and Dexamethasone Injection in the Symptomatic Management of Stage II Oral Submucous Fibrosis - a Prospective Study.病灶内注射胎盘组织液与透明质酸酶及地塞米松注射治疗II期口腔黏膜下纤维化症状的比较——一项前瞻性研究
Indian J Otolaryngol Head Neck Surg. 2023 Dec;75(4):3530-3534. doi: 10.1007/s12070-023-04016-5. Epub 2023 Jul 4.
7
Efficacy of oral colchicine with intralesional hyaluronidase or triamcinolone acetonide in the Grade II oral submucous fibrosis.口服秋水仙碱联合病灶内注射透明质酸酶或曲安奈德治疗Ⅱ级口腔黏膜下纤维化的疗效
Natl J Maxillofac Surg. 2017 Jan-Jun;8(1):50-54. doi: 10.4103/njms.NJMS_5_17.
8
Management of Oral Submucous Fibrosis with Injection of Hyaluronidase and Dexamethasone in Grade III Oral Submucous Fibrosis: A Retrospective Study.透明质酸酶和地塞米松注射治疗Ⅲ级口腔黏膜下纤维化的回顾性研究
J Int Oral Health. 2015 Aug;7(8):82-5.
9
Evaluation of Oral Pentoxifylline in the Management of Oral Submucous Fibrosis - An Ultrasonographic Study.口服己酮可可碱治疗口腔黏膜下纤维化的超声研究评估
Contemp Clin Dent. 2017 Apr-Jun;8(2):200-204. doi: 10.4103/ccd.ccd_1192_16.
10
Comparison Between Clinical Outcome of Intralesional Human Placental Extract Alone and Topical Application of Placental Extract Gel After Fibrotomy in Oral Submucous Fibrosis.口腔黏膜下纤维化行纤维切除术单独病灶内注射人胎盘提取物与局部应用胎盘提取物凝胶后的临床疗效比较
Cureus. 2023 Jun 7;15(6):e40105. doi: 10.7759/cureus.40105. eCollection 2023 Jun.

引用本文的文献

1
Effect of oral alpha lipoic acid in treatment of OSMF.口服α-硫辛酸治疗口腔黏膜下纤维化的效果
Bioinformation. 2024 Oct 31;20(10):1401-1404. doi: 10.6026/9732063002001401. eCollection 2024.

本文引用的文献

1
Management of Oral Submucous Fibrosis with Injection of Hyaluronidase and Dexamethasone in Grade III Oral Submucous Fibrosis: A Retrospective Study.透明质酸酶和地塞米松注射治疗Ⅲ级口腔黏膜下纤维化的回顾性研究
J Int Oral Health. 2015 Aug;7(8):82-5.
2
Benefit of using muscle relaxants in the routine treatment protocol of oral submucosal fibrosis: a pilot study.在口腔黏膜下纤维化常规治疗方案中使用肌肉松弛剂的益处:一项初步研究。
Indian J Otolaryngol Head Neck Surg. 2011 Oct;63(4):317-20. doi: 10.1007/s12070-011-0234-6. Epub 2011 Sep 9.
3
Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis.血管扩张药异舒普林可缓解口腔黏膜下纤维性变的症状。
Clin Oral Investig. 2013 Jun;17(5):1375-82. doi: 10.1007/s00784-012-0824-z. Epub 2012 Aug 15.
4
Pentoxifylline therapy in the management of oral submucous fibrosis.己酮可可碱疗法在口腔黏膜下纤维化治疗中的应用
Asian Pac J Cancer Prev. 2011;12(4):971-4.
5
Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis.醋酸氢化可的松/透明质酸酶与曲安奈德/透明质酸酶治疗口腔黏膜下纤维性变的疗效比较。
Indian J Med Res. 2010 May;131:665-9.
6
Lack of reliable evidence for oral submucous fibrosis treatments.
Evid Based Dent. 2009;10(1):8-9. doi: 10.1038/sj.ebd.6400625.
7
Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature.口腔黏膜下纤维化,一种临床良性但有潜在恶变可能的疾病:3例报告及文献复习
J Can Dent Assoc. 2008 Oct;74(8):735-40.
8
Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis.己酮可可碱疗法:口腔黏膜下纤维化治疗的一种新辅助方法。
Indian J Dent Res. 2006 Oct-Dec;17(4):190-8. doi: 10.4103/0970-9290.29865.
9
Cancer of the buccal mucosa; a clinical study of 650 cases in Indian patients.颊黏膜癌;对650例印度患者的临床研究
Cancer. 1956 May-Jun;9(3):431-5. doi: 10.1002/1097-0142(195605/06)9:3<431::aid-cncr2820090302>3.0.co;2-t.
10
Serum protein, ascorbic acid & iron & tissue collagen in oral submucous fibrosis--a preliminary study.口腔黏膜下纤维化中的血清蛋白、抗坏血酸、铁与组织胶原蛋白——一项初步研究。
Indian J Med Res. 1993 Jun;98:147-51.